Enhancer Provides a Potential Target for 'Undruggable' MYC in Pediatric Medulloblastoma

A tumor-specific enhancer on extrachromosomal DNA drives MYC expression, revealing a new therapeutic target in high-risk pediatric medulloblastoma.